Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction

Fig. 1

Change in Plasmodium vivax parasitemia among follow-up samples collected from day-0 (the day when the patient was admitted to the hospital and sought antimalarial treatment) to up to 6-months after treatment. Samples with cleared parasitemia at day-2 a, day-3 b, at day-7 and after c, and with recurred parasitemia d were presented. For the samples that showed recurred infection, the initial and recurred genotypes were found to be different based on microsatellites, suggestive of a newly infected parasite strain that caused recurred parasitemia after initial drug treatment

Back to article page